BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  Xpert® Mpox Receives Emergency Use Listing by World Health Organization

  November 5, 2024

   · 

  2 min read
• Press Releases

  Boston Scientific Announces Agreement to Acquire Cortex, Inc.

  November 5, 2024

   · 

  7 min read
• Press Releases

  KalVista Pharmaceuticals Announces Pricing of a $55 Million Underwritten Offering of Common Stock and Concurrent Private Placement of $5 Million

  November 5, 2024

   · 

  6 min read
• Press Releases

  Spectral Medical Provides October Tigris Trial Update

  November 5, 2024

   · 

  3 min read
• Press Releases

  KalVista Pharmaceuticals Enters into Non-Dilutive Synthetic Royalty Financing with DRI Healthcare Trust

  November 5, 2024

   · 

  6 min read
• Press Releases

  Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval

  November 5, 2024

   · 

  8 min read
• Press Releases

  Y-mAbs and Nobelpharma Announce Exclusive License and Distribution Agreement for DANYELZA® (naxitamab-gqgk) in Japan

  November 5, 2024

   · 

  5 min read
• Press Releases

  Editas Medicine Announces Third Quarter 2024 Results and Business Updates

  November 5, 2024

   · 

  11 min read
• Press Releases

  Angitia Biopharmaceuticals Announces Dosing of First Patient in Phase 2 Clinical Trial of AGA2118 for the Treatment of Osteoporosis

  November 5, 2024

   · 

  4 min read
• Press Releases

  Incyclix Bio Announces Abstract Accepted for Presentation at 2024 San Antonio Breast Cancer Symposium

  November 5, 2024

   · 

  1 min read